Distinct Markers of Discordant Treatment Response to Lifestyle Intervention in MASLD, Independent of Weight Loss

<b>Background/Objectives:</b> Weight loss is the primary therapy for metabolic dysfunction-associated steatotic liver disease (MASLD). However, the proportion and factors influencing therapeutic changes in the liver condition contrary to weight loss remain unclear. <b>Methods</b>: This observational...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ling Luo, Congxiang Shao, Zhi Dong, Shuyu Zhuo, Shiting Feng, Wei Wang, Junzhao Ye, Bihui Zhong
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2025-09-01
סדרה:	Biomedicines
נושאים:	metabolic dysfunction-associated steatotic liver disease treatment response weight loss lifestyle intervention
גישה מקוונת:	https://www.mdpi.com/2227-9059/13/9/2161
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!